{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:19:58Z","timestamp":1787980798429,"version":"build-2784847793"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jaad.2015.11.021","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T12:09:58Z","timestamp":1455624598000},"page":"574-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study"],"prefix":"10.1016","volume":"74","author":[{"given":"Fran\u00e7ois","family":"Aubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Avenel-Audran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Jeanmougin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Adamski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Peyron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Marguery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"L\u00e9onard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Puyraveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuelle","family":"Viguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2015.11.021_bib1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s40265-014-0290-9","article-title":"Omalizumab: a review of its use in patients with chronic spontaneous urticaria","volume":"74","author":"McCormark","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2015.11.021_bib2","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1398-9995.2008.01879.x","article-title":"Successful treatment of solar urticaria with anti-immunoglobulin E therapy","volume":"63","author":"Guzelbey","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2015.11.021_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaci.2009.11.007","article-title":"Partial improvement of solar urticaria after omalizumab","volume":"125","author":"Waibel","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2015.11.021_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-0781.2011.00624.x","article-title":"Failure of omalizumab (Xolair\u00ae) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light","volume":"27","author":"Duchini","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2015.11.021_bib5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaad.2014.07.023","article-title":"Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study","volume":"71","author":"Aubin","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215024925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215024925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:39:36Z","timestamp":1759271976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215024925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0190962215024925"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.11.021","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}